TY - JOUR AU - Lauer, M. i. c. h. a. e. l. S. AU - Gordon, D. a. v. i. d. AU - Wei, G. i. n. a. AU - Pearson, G. a. i. l. PY - 2017 DA - 2017// TI - Efficient design of clinical trials and epidemiological research: is it possible? JO - Nature Reviews Cardiology VL - 14 UR - https://doi.org/10.1038/nrcardio.2017.60 DO - 10.1038/nrcardio.2017.60 ID - Lauer2017 ER - TY - JOUR AU - O’Neill, R. T. PY - 2006 DA - 2006// TI - FDA’s critical path initiative: a perspective on contributions of biostatistics JO - Biom J VL - 48 UR - https://doi.org/10.1002/bimj.200510237 DO - 10.1002/bimj.200510237 ID - O’Neill2006 ER - TY - JOUR AU - Chow, S. -. C. PY - 2014 DA - 2014// TI - Adaptive clinical trial design JO - Annu Rev Med. Annual Reviews VL - 65 UR - https://doi.org/10.1146/annurev-med-092012-112310 DO - 10.1146/annurev-med-092012-112310 ID - Chow2014 ER - TY - BOOK PY - 2007 DA - 2007// TI - Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design ID - ref4 ER - TY - BOOK PY - 2010 DA - 2010// TI - Guidance for industry: adaptive design clinical trials for drugs and biologics ID - ref5 ER - TY - BOOK PY - 2015 DA - 2015// TI - Adaptive designs for medical device clinical studies: draft guidance for industry and Food and Drug Administration staff ID - ref6 ER - TY - JOUR AU - Bauer, P. AU - Bretz, F. AU - Dragalin, V. AU - König, F. AU - Wassmer, G. PY - 2016 DA - 2016// TI - Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls JO - Stat Med VL - 35 UR - https://doi.org/10.1002/sim.6472 DO - 10.1002/sim.6472 ID - Bauer2016 ER - TY - JOUR AU - Bretz, F. AU - Koenig, F. AU - Brannath, W. AU - Glimm, E. AU - Posch, M. PY - 2009 DA - 2009// TI - Adaptive designs for confirmatory clinical trials JO - Stat Med VL - 28 UR - https://doi.org/10.1002/sim.3538 DO - 10.1002/sim.3538 ID - Bretz2009 ER - TY - JOUR AU - Pallmann, P. AU - Bedding, A. W. AU - Choodari-Oskooei, B. AU - Dimairo, M. AU - Flight, L. AU - Hampson, L. V. PY - 2018 DA - 2018// TI - Adaptive designs in clinical trials: why use them, and how to run and report them JO - BMC Med. BioMed Central VL - 16 ID - Pallmann2018 ER - TY - JOUR AU - Guetterman, T. C. AU - Fetters, M. D. AU - Legocki, L. J. AU - Mawocha, S. AU - Barsan, W. G. AU - Lewis, R. J. PY - 2015 DA - 2015// TI - Reflections on the adaptive designs accelerating promising trials into treatments (ADAPT-IT) process-findings from a qualitative study JO - Clin Res Regul Aff VL - 32 UR - https://doi.org/10.3109/10601333.2015.1079217 DO - 10.3109/10601333.2015.1079217 ID - Guetterman2015 ER - TY - STD TI - Rong Y. Regulations on adaptive design clinical trials. Pharm Regul Aff Open Access. OMICS International; 2014;03. ID - ref11 ER - TY - JOUR AU - Quinlan, J. AU - Krams, M. PY - 2006 DA - 2006// TI - Implementing adaptive designs: logistical and operational considerations JO - Drug Inf J. VL - 40 UR - https://doi.org/10.1177/216847900604000409 DO - 10.1177/216847900604000409 ID - Quinlan2006 ER - TY - JOUR AU - Gaydos, B. AU - Anderson, K. M. AU - Berry, D. AU - Burnham, N. AU - Chuang-Stein, C. AU - Dudinak, J. PY - 2009 DA - 2009// TI - Good practices for adaptive clinical trials in pharmaceutical product development JO - Drug Inf J VL - 43 UR - https://doi.org/10.1177/009286150904300503 DO - 10.1177/009286150904300503 ID - Gaydos2009 ER - TY - JOUR AU - Thorlund, K. AU - Haggstrom, J. AU - Park, J. J. AU - Mills, E. J. PY - 2018 DA - 2018// TI - Key design considerations for adaptive clinical trials: a primer for clinicians JO - BMJ. British Medical Journal Publishing Group VL - 360 UR - https://doi.org/10.1136/bmj.k698 DO - 10.1136/bmj.k698 ID - Thorlund2018 ER - TY - JOUR AU - Park, J. J. AU - Thorlund, K. AU - Mills, E. J. PY - 2018 DA - 2018// TI - Critical concepts in adaptive clinical trials JO - Clin Epidemiol. Dove Press VL - 10 UR - https://doi.org/10.2147/CLEP.S156708 DO - 10.2147/CLEP.S156708 ID - Park2018 ER - TY - JOUR AU - Chow, S. -. C. AU - Chang, M. PY - 2008 DA - 2008// TI - Adaptive design methods in clinical trials - a review JO - Orphanet J Rare Dis. VL - 3 UR - https://doi.org/10.1186/1750-1172-3-11 DO - 10.1186/1750-1172-3-11 ID - Chow2008 ER - TY - STD TI - Jaki T. Designing multi-arm multi-stage clinical studies. Developments in Statistical Evaluation of Clinical Trials. Springer; 2014. p. 51–69. Available from: http://link.springer.com/10.1007/978-3-642-55345-5_3. UR - http://link.springer.com/10.1007/978-3-642-55345-5_3 ID - ref17 ER - TY - JOUR AU - Hatfield, I. AU - Allison, A. AU - Flight, L. AU - Julious, S. A. AU - Dimairo, M. PY - 2016 DA - 2016// TI - Adaptive designs undertaken in clinical research: a review of registered clinical trials JO - Trials. BioMed Central VL - 17 ID - Hatfield2016 ER - TY - JOUR AU - Sato, A. AU - Shimura, M. AU - Gosho, M. PY - 2017 DA - 2017// TI - Practical characteristics of adaptive design in phase 2 and 3 clinical trials JO - Journal of Clinical Pharmacy and Therapeutics VL - 43 UR - https://doi.org/10.1111/jcpt.12617 DO - 10.1111/jcpt.12617 ID - Sato2017 ER - TY - JOUR AU - Lin, M. AU - Lee, S. AU - Zhen, B. AU - Scott, J. AU - Horne, A. AU - Solomon, G. PY - 2015 DA - 2015// TI - CBER’s experience with adaptive design clinical trials JO - Ther Innov Regul Sci. VL - 50 UR - https://doi.org/10.1177/2168479015604181 DO - 10.1177/2168479015604181 ID - Lin2015 ER - TY - JOUR AU - Yang, X. AU - Thompson, L. AU - Chu, J. AU - Liu, S. AU - Lu, H. AU - Zhou, J. PY - 2016 DA - 2016// TI - Adaptive design practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013 JO - Ther Innov Regul Sci. SAGE Publications VL - 50 ID - Yang2016 ER - TY - JOUR AU - Morgan, C. C. AU - Huyck, S. AU - Jenkins, M. AU - Chen, L. AU - Bedding, A. AU - Coffey, C. S. PY - 2014 DA - 2014// TI - Adaptive design: results of 2012 survey on perception and use JO - Ther Innov Regul Sci. VL - 48 UR - https://doi.org/10.1177/2168479014522468 DO - 10.1177/2168479014522468 ID - Morgan2014 ER - TY - JOUR AU - Bauer, P. AU - Einfalt, J. PY - 2006 DA - 2006// TI - Application of adaptive designs – a review JO - Biom J VL - 48 UR - https://doi.org/10.1002/bimj.200510204 DO - 10.1002/bimj.200510204 ID - Bauer2006 ER - TY - JOUR AU - Curtin, F. r. a. n. ç. o. i. s. AU - Heritier, S. t. e. p. h. a. n. e. PY - 2017 DA - 2017// TI - The role of adaptive trial designs in drug development JO - Expert Review of Clinical Pharmacology VL - 10 UR - https://doi.org/10.1080/17512433.2017.1321985 DO - 10.1080/17512433.2017.1321985 ID - Curtin2017 ER - TY - JOUR AU - Elsäßer, A. AU - Regnstrom, J. AU - Vetter, T. AU - Koenig, F. AU - Hemmings, R. J. AU - Greco, M. PY - 2014 DA - 2014// TI - Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency JO - Trials VL - 15 UR - https://doi.org/10.1186/1745-6215-15-383 DO - 10.1186/1745-6215-15-383 ID - Elsäßer2014 ER - TY - JOUR AU - Dimairo, M. AU - Boote, J. AU - Julious, S. A. AU - Nicholl, J. P. AU - Todd, S. PY - 2015 DA - 2015// TI - Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials JO - Trials. BioMed Central Ltd VL - 16 ID - Dimairo2015 ER - TY - JOUR AU - Meurer, W. J. AU - Legocki, L. AU - Mawocha, S. AU - Frederiksen, S. M. AU - Guetterman, T. C. AU - Barsan, W. PY - 2016 DA - 2016// TI - Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project JO - Trials. BioMed Central VL - 17 ID - Meurer2016 ER - TY - JOUR AU - Dimairo, M. AU - Julious, S. A. AU - Todd, S. AU - Nicholl, J. P. AU - Boote, J. PY - 2015 DA - 2015// TI - Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials JO - Trials. BioMed Central Ltd VL - 16 ID - Dimairo2015 ER - TY - JOUR AU - Love, S. B. AU - Brown, S. AU - Weir, C. J. AU - Harbron, C. AU - Yap, C. AU - Gaschler-Markefski, B. PY - 2017 DA - 2017// TI - Embracing model-based designs for dose-finding trials JO - Br J Cancer. Nature Publishing Group VL - 117 ID - Love2017 ER - TY - JOUR AU - Jaki, T. PY - 2013 DA - 2013// TI - Uptake of novel statistical methods for early-phase clinical studies in the UK public sector JO - Clin Trials. VL - 10 UR - https://doi.org/10.1177/1740774512474375 DO - 10.1177/1740774512474375 ID - Jaki2013 ER - TY - JOUR AU - Quinlan, J. AU - Gaydos, B. AU - Maca, J. AU - Krams, M. PY - 2010 DA - 2010// TI - Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development JO - Clin Trials VL - 7 UR - https://doi.org/10.1177/1740774510361542 DO - 10.1177/1740774510361542 ID - Quinlan2010 ER - TY - JOUR AU - Coffey, C. S. AU - Levin, B. AU - Clark, C. AU - Timmerman, C. AU - Wittes, J. AU - Gilbert, P. PY - 2012 DA - 2012// TI - Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop JO - Clin Trials. VL - 9 UR - https://doi.org/10.1177/1740774512461859 DO - 10.1177/1740774512461859 ID - Coffey2012 ER - TY - STD TI - Dimairo M. The utility of adaptive designs in publicly funded confirmatory trials. 2016. http://etheses.whiterose.ac.uk/13981. Accessed 7 July 2017. UR - http://etheses.whiterose.ac.uk/13981 ID - ref33 ER - TY - JOUR AU - Stevely, A. AU - Dimairo, M. AU - Todd, S. AU - Julious, S. A. AU - Nicholl, J. AU - Hind, D. PY - 2015 DA - 2015// TI - An investigation of the shortcomings of the CONSORT 2010 statement for the reporting of group sequential randomised controlled trials: a methodological systematic review JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0141104 DO - 10.1371/journal.pone.0141104 ID - Stevely2015 ER - TY - JOUR AU - Mistry, P. AU - Dunn, J. A. AU - Marshall, A. PY - 2017 DA - 2017// TI - A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines JO - BMC Med Res Methodol. BMC Medical Research Methodology VL - 17 UR - https://doi.org/10.1186/s12874-017-0393-6 DO - 10.1186/s12874-017-0393-6 ID - Mistry2017 ER - TY - STD TI - Stevely A, Dimairo M, Todd S, Julious SA, Nicholl J, Hind D, et al. An investigation of the shortcomings of the CONSORT 2010 Statement for the reporting of group sequential randomised controlled trials: a methodological systematic review. Shamji M, editors. PLoS One. Public Library of Science; 2015;10:e0141104. ID - ref36 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials JO - Ann Intern Med VL - 152 UR - https://doi.org/10.7326/0003-4819-152-11-201006010-00232 DO - 10.7326/0003-4819-152-11-201006010-00232 ID - Schulz2010 ER - TY - STD TI - Detry MA, Lewis RJ, Broglio KR, Connor JT, Berry SM, Berry DA. Standards for the design, conduct, and evaluation of adaptive randomized clinical trials. Washington: Patient-Centered Outcomes Research Institute; 2012. http://www.pcori.org/assets/Standards-for-the-Design-Conduct-and-Evaluation-of-Adaptive-Randomized-Clinical-Trials.pdf. Accessed 7 July 2017. UR - http://www.pcori.org/assets/Standards-for-the-Design-Conduct-and-Evaluation-of-Adaptive-Randomized-Clinical-Trials.pdf ID - ref38 ER - TY - JOUR AU - Moher, D. AU - Schulz, K. F. AU - Simera, I. AU - Altman, D. G. PY - 2010 DA - 2010// TI - Guidance for developers of health research reporting guidelines JO - PLoS Med. Public Library of Science VL - 7 ID - Moher2010 ER - TY - STD TI - Dimairo M, Todd S, Julious S, Jaki T, Wason J, Hind D, et al. ACE Project Protocol Version 2.3: development of a CONSORT Extension for adaptive clinical trials [Internet]. EQUATOR Netw. 2016 [cited 2018 Jan 25]. Available from: http://www.equator-network.org/wp-content/uploads/2017/12/ACE-Project-Protocol-v2.3.pdf UR - http://www.equator-network.org/wp-content/uploads/2017/12/ACE-Project-Protocol-v2.3.pdf ID - ref40 ER - TY - JOUR AU - Kairalla, J. A. AU - Coffey, C. S. AU - Thomann, M. A. AU - Muller, K. E. PY - 2012 DA - 2012// TI - Adaptive trial designs: a review of barriers and opportunities JO - Trials VL - 13 UR - https://doi.org/10.1186/1745-6215-13-145 DO - 10.1186/1745-6215-13-145 ID - Kairalla2012 ER - TY - STD TI - The EQUATOR Network [Internet]. [cited 2016 Oct 10]. Available from: http://www.equator-network.org/reporting-guidelines/. UR - http://www.equator-network.org/reporting-guidelines/ ID - ref42 ER - TY - JOUR AU - Dragalin, V. PY - 2006 DA - 2006// TI - Adaptive designs: terminology and classification JO - Drug Inf J VL - 40 UR - https://doi.org/10.1177/216847900604000408 DO - 10.1177/216847900604000408 ID - Dragalin2006 ER - TY - JOUR AU - Cook, T. AU - DeMets, D. L. PY - 2010 DA - 2010// TI - Review of draft FDA adaptive design guidance JO - J Biopharm Stat VL - 20 UR - https://doi.org/10.1080/10543406.2010.514455 DO - 10.1080/10543406.2010.514455 ID - Cook2010 ER - TY - JOUR AU - Chow, S. -. C. AU - Corey, R. PY - 2011 DA - 2011// TI - Benefits, challenges and obstacles of adaptive clinical trial designs JO - Orphanet J Rare Dis VL - 6 UR - https://doi.org/10.1186/1750-1172-6-79 DO - 10.1186/1750-1172-6-79 ID - Chow2011 ER - TY - JOUR AU - Gallo, P. AU - Chuang-Stein, C. AU - Dragalin, V. AU - Gaydos, B. AU - Krams, M. AU - Pinheiro, J. PY - 2006 DA - 2006// TI - Adaptive designs in clinical drug development--an executive summary of the PhRMA Working Group JO - J Biopharm Stat VL - 16 UR - https://doi.org/10.1080/10543400600614742 DO - 10.1080/10543400600614742 ID - Gallo2006 ER - TY - BOOK AU - Rosenberg, M. J. PY - 2010 DA - 2010// TI - The agile approach to adaptive research: optimizing efficiency in clinical development PB - Sons, Inc CY - Hoboken UR - https://doi.org/10.1002/9780470599686 DO - 10.1002/9780470599686 ID - Rosenberg2010 ER - TY - JOUR AU - Brown, C. H. AU - Ten Have, T. R. AU - Jo, B. AU - Dagne, G. AU - Wyman, P. A. AU - Muthén, B. PY - 2009 DA - 2009// TI - Adaptive designs for randomized trials in public health JO - Annu Rev Public Health. NIH Public Access VL - 30 UR - https://doi.org/10.1146/annurev.publhealth.031308.100223 DO - 10.1146/annurev.publhealth.031308.100223 ID - Brown2009 ER - TY - JOUR AU - Wang, S. u. e. -. J. a. n. e. AU - Hung, H. M. J. a. m. e. s. AU - O'Neill, R. o. b. e. r. t. PY - 2011 DA - 2011// TI - Adaptive design clinical trials and trial logistics models in CNS drug development JO - European Neuropsychopharmacology VL - 21 UR - https://doi.org/10.1016/j.euroneuro.2010.09.003 DO - 10.1016/j.euroneuro.2010.09.003 ID - Wang2011 ER - TY - JOUR AU - Elman, S. A. AU - Ware, J. H. AU - Gottlieb, A. B. AU - Merola, J. F. PY - 2016 DA - 2016// TI - Adaptive clinical trial design: an overview and potential applications in dermatology JO - J Invest Dermatol VL - 136 UR - https://doi.org/10.1016/j.jid.2016.02.807 DO - 10.1016/j.jid.2016.02.807 ID - Elman2016 ER - TY - JOUR AU - Porcher, R. AU - Lecocq, B. AU - Vray, M. AU - D’Andon, A. AU - Bassompierre, F. AU - Béhier, J. -. M. PY - 2011 DA - 2011// TI - Adaptive methods: when and how should they be used in clinical trials? JO - Therapie VL - 66 UR - https://doi.org/10.2515/therapie/2011044 DO - 10.2515/therapie/2011044 ID - Porcher2011 ER - TY - JOUR AU - Maca, J. AU - Dragalin, V. AU - Gallo, P. PY - 2014 DA - 2014// TI - Adaptive clinical trials: overview of phase III designs and challenges JO - Ther Innov Regul Sci. VL - 48 UR - https://doi.org/10.1177/2168479013507436 DO - 10.1177/2168479013507436 ID - Maca2014 ER - TY - JOUR AU - Bauer, P. AU - Brannath, W. PY - 2004 DA - 2004// TI - The advantages and disadvantages of adaptive designs for clinical trials JO - Drug Discov Today VL - 9 UR - https://doi.org/10.1016/S1359-6446(04)03023-5 DO - 10.1016/S1359-6446(04)03023-5 ID - Bauer2004 ER - TY - JOUR AU - Coffey, C. S. AU - Kairalla, J. A. PY - 2008 DA - 2008// TI - Adaptive clinical trials: progress and challenges JO - Drugs R D VL - 9 UR - https://doi.org/10.2165/00126839-200809040-00003 DO - 10.2165/00126839-200809040-00003 ID - Coffey2008 ER - TY - JOUR AU - Gallo, P. PY - 2006 DA - 2006// TI - Operational challenges in adaptive design implementation JO - Pharm Stat. John Wiley & Sons, Ltd. VL - 5 ID - Gallo2006 ER - TY - JOUR AU - Gaydos, B. AU - Anderson, K. M. AU - Berry, D. AU - Burnham, N. AU - Chuang-Stein, C. AU - Dudinak, J. PY - 2009 DA - 2009// TI - Good practices for adaptive clinical trials in pharmaceutical product development JO - Ther Innov Regul Sci VL - 43 ID - Gaydos2009 ER - TY - JOUR AU - Phillips, A. J. AU - Keene, O. N. PY - 2006 DA - 2006// TI - Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group JO - Pharm Stat. John Wiley & Sons, Ltd. VL - 5 ID - Phillips2006 ER - TY - JOUR AU - Gould, A. L. PY - 2006 DA - 2006// TI - How practical are adaptive designs likely to be for confirmatory trials? JO - Biom J VL - 48 UR - https://doi.org/10.1002/bimj.200610242 DO - 10.1002/bimj.200610242 ID - Gould2006 ER - TY - JOUR AU - Spencer, K. AU - Colvin, K. AU - Braunecker, B. AU - Brackman, M. AU - Ripley, J. AU - Hines, P. PY - 2012 DA - 2012// TI - Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study JO - J Diabetes Sci Technol VL - 6 UR - https://doi.org/10.1177/193229681200600608 DO - 10.1177/193229681200600608 ID - Spencer2012 ER - TY - JOUR AU - Koch, A. PY - 2006 DA - 2006// TI - Confirmatory clinical trials with an adaptive design JO - Biom J VL - 48 UR - https://doi.org/10.1002/bimj.200510239 DO - 10.1002/bimj.200510239 ID - Koch2006 ER - TY - JOUR AU - Chuang-Stein, C. AU - Beltangady, M. PY - 2010 DA - 2010// TI - FDA draft guidance on adaptive design clinical trials: Pfizer’s perspective JO - J Biopharm Stat VL - 20 UR - https://doi.org/10.1080/10543406.2010.514456 DO - 10.1080/10543406.2010.514456 ID - Chuang-Stein2010 ER - TY - JOUR AU - Eldridge, S. M. AU - Chan, C. L. AU - Campbell, M. J. AU - Bond, C. M. AU - Hopewell, S. AU - Thabane, L. PY - 2016 DA - 2016// TI - CONSORT 2010 statement: extension to randomised pilot and feasibility trials JO - Pilot Feasibility Stud. BioMed Central VL - 2 UR - https://doi.org/10.1186/s40814-016-0105-8 DO - 10.1186/s40814-016-0105-8 ID - Eldridge2016 ER - TY - JOUR AU - Kirkham, J. J. AU - Gorst, S. AU - Altman, D. G. AU - Blazeby, J. AU - Clarke, M. AU - Devane, D. PY - 2015 DA - 2015// TI - COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) JO - Trials. BioMed Central VL - 16 ID - Kirkham2015 ER - TY - JOUR AU - Gamble, C. AU - Krishan, A. AU - Stocken, D. AU - Lewis, S. AU - Juszczak, E. AU - Doré, C. PY - 2017 DA - 2017// TI - Guidelines for the content of statistical analysis plans in clinical trials JO - JAMA. American Medical Association VL - 318 UR - https://doi.org/10.1001/jama.2017.18556 DO - 10.1001/jama.2017.18556 ID - Gamble2017 ER - TY - JOUR AU - Moher, D. AU - Hopewell, S. AU - Schulz, K. F. AU - Montori, V. AU - Gøtzsche, P. C. AU - Devereaux, P. J. PY - 2010 DA - 2010// TI - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c869 DO - 10.1136/bmj.c869 ID - Moher2010 ER - TY - JOUR AU - Diamond, I. R. AU - Grant, R. C. AU - Feldman, B. M. AU - Pencharz, P. B. AU - Ling, S. C. AU - Moore, A. M. PY - 2014 DA - 2014// TI - Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies JO - J Clin Epidemiol VL - 67 UR - https://doi.org/10.1016/j.jclinepi.2013.12.002 DO - 10.1016/j.jclinepi.2013.12.002 ID - Diamond2014 ER - TY - JOUR AU - Braun, V. AU - Clarke, V. PY - 2006 DA - 2006// TI - Using thematic analysis in psychology JO - Qual Res Psychol VL - 3 UR - https://doi.org/10.1191/1478088706qp063oa DO - 10.1191/1478088706qp063oa ID - Braun2006 ER - TY - JOUR AU - Landis, J. R. AU - Koch, G. G. PY - 1977 DA - 1977// TI - The measurement of observer agreement for categorical data JO - Biometrics VL - 33 UR - https://doi.org/10.2307/2529310 DO - 10.2307/2529310 ID - Landis1977 ER - TY - JOUR AU - Efron, B. PY - 1979 DA - 1979// TI - Bootstrap methods: another look at the jackknife JO - Ann Stat. Institute of Mathematical Statistics VL - 7 ID - Efron1979 ER - TY - JOUR AU - Bland, M. AU - Altman, D. PY - 1986 DA - 1986// TI - Statistical methods for assessing agreement between two methods of clinical measurement JO - Lancet. Elsevier VL - 327 UR - https://doi.org/10.1016/S0140-6736(86)90837-8 DO - 10.1016/S0140-6736(86)90837-8 ID - Bland1986 ER - TY - JOUR AU - Akacha, M. AU - Bretz, F. AU - Ruberg, S. PY - 2017 DA - 2017// TI - Estimands in clinical trials – broadening the perspective JO - Stat Med VL - 36 UR - https://doi.org/10.1002/sim.7033 DO - 10.1002/sim.7033 ID - Akacha2017 ER - TY - JOUR AU - Akacha, M. AU - Bretz, F. AU - Ohlssen, D. AU - Rosenkranz, G. AU - Schmidli, H. PY - 2017 DA - 2017// TI - Estimands and their role in clinical trials JO - Stat Biopharm Res. Taylor & Francis VL - 9 UR - https://doi.org/10.1080/19466315.2017.1302358 DO - 10.1080/19466315.2017.1302358 ID - Akacha2017 ER - TY - JOUR AU - Phillips, A. AU - Abellan-Andres, J. AU - Soren, A. AU - Bretz, F. AU - Fletcher, C. AU - France, L. PY - 2017 DA - 2017// TI - Estimands: discussion points from the PSI estimands and sensitivity expert group JO - Pharm Stat VL - 16 UR - https://doi.org/10.1002/pst.1745 DO - 10.1002/pst.1745 ID - Phillips2017 ER - TY - STD TI - Extensions of the CONSORT Statement [Internet]. [cited 2018 May 21]. Available from: http://www.consort-statement.org/extensions. UR - http://www.consort-statement.org/extensions ID - ref74 ER - TY - JOUR AU - Blanco, D. AU - Biggane, A. M. AU - Cobo, E. PY - 2018 DA - 2018// TI - Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers? JO - Trials. BioMed Central VL - 19 ID - Blanco2018 ER - TY - JOUR AU - Agha, R. A. AU - Fowler, A. J. AU - Rajmohan, S. AU - Barai, I. AU - Orgill, D. P. AU - Afifi, R. PY - 2016 DA - 2016// TI - Preferred reporting of case series in surgery; the PROCESS guidelines JO - Int J Surg VL - 36 UR - https://doi.org/10.1016/j.ijsu.2016.10.025 DO - 10.1016/j.ijsu.2016.10.025 ID - Agha2016 ER - TY - JOUR AU - Vohra, S. u. n. i. t. a. AU - Shamseer, L. a. r. i. s. s. a. AU - Sampson, M. a. r. g. a. r. e. t. AU - Bukutu, C. e. c. i. l. i. a. AU - Schmid, C. h. r. i. s. t. o. p. h. e. r. H. AU - Tate, R. o. b. y. n. AU - Nikles, J. a. n. e. AU - Zucker, D. e. b. o. r. a. h. R. AU - Kravitz, R. i. c. h. a. r. d. AU - Guyatt, G. o. r. d. o. n. AU - Altman, D. o. u. g. l. a. s. G. AU - Moher, D. a. v. i. d. AU - Altman, D. o. u. g. l. a. s. G. AU - Bukutu, C. e. c. i. l. i. a. AU - Clark, J. o. c. a. l. y. n. AU - Cogo, E. l. i. s. e. AU - Gabler, N. i. c. o. l. e. B. AU - Guyatt, G. o. r. d. o. n. AU - Kravitz, R. i. c. h. a. r. d. AU - Janosky, J. a. n. i. n. e. AU - Johnston, B. r. a. d. l. e. y. C. AU - Li, B. o. b. AU - Mahon, J. e. f. f. AU - Marles, R. o. b. i. n. AU - Moher, D. a. v. i. d. AU - Nikles, J. a. n. e. AU - Sampson, M. a. r. g. a. r. e. t. AU - Schmid, C. h. r. i. s. t. o. p. h. e. r. H. AU - Shadish, W. i. l. l. i. a. m. R. AU - Shamseer, L. a. r. i. s. s. a. AU - Tate, R. o. b. y. n. AU - Vohra, S. u. n. i. t. a. AU - Zucker, D. e. b. o. r. a. h. R. PY - 2016 DA - 2016// TI - CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement JO - Journal of Clinical Epidemiology VL - 76 UR - https://doi.org/10.1016/j.jclinepi.2015.05.004 DO - 10.1016/j.jclinepi.2015.05.004 ID - Vohra2016 ER - TY - JOUR AU - Gagnier, J. J. AU - Kienle, G. AU - Altman, D. G. AU - Moher, D. AU - Sox, H. AU - Riley, D. PY - 2013 DA - 2013// TI - The CARE guidelines: consensus-based clinical case reporting guideline development JO - Glob Adv Heal Med. SAGE Publications VL - 2 UR - https://doi.org/10.7453/gahmj.2013.008 DO - 10.7453/gahmj.2013.008 ID - Gagnier2013 ER - TY - JOUR AU - Husereau, D. AU - Drummond, M. AU - Petrou, S. AU - Carswell, C. AU - Moher, D. AU - Greenberg, D. PY - 2013 DA - 2013// TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force JO - Value Heal. Elsevier VL - 16 UR - https://doi.org/10.1016/j.jval.2013.02.002 DO - 10.1016/j.jval.2013.02.002 ID - Husereau2013 ER - TY - JOUR AU - Eldridge, S. M. AU - Chan, C. L. AU - Campbell, M. J. AU - Bond, C. M. AU - Hopewell, S. AU - Thabane, L. PY - 2016 DA - 2016// TI - CONSORT 2010 statement: extension to randomised pilot and feasibility trials JO - BMJ. BMJ Publishing Group VL - 355 ID - Eldridge2016 ER - TY - JOUR AU - Stevens, G. A. AU - Alkema, L. AU - Black, R. E. AU - Boerma, J. T. AU - Collins, G. S. AU - Ezzati, M. PY - 2016 DA - 2016// TI - Guidelines for accurate and transparent health estimates reporting: the GATHER statement JO - PLoS Med. Public Library of Science VL - 13 ID - Stevens2016 ER - TY - JOUR AU - Bothwell, L. E. AU - Avorn, J. AU - Khan, N. F. AU - Kesselheim, A. S. PY - 2018 DA - 2018// TI - Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov JO - BMJ Open. British Medical Journal Publishing Group VL - 8 ID - Bothwell2018 ER - TY - JOUR AU - Lorch, U. AU - O’Kane, M. AU - Taubel, J. PY - 2014 DA - 2014// TI - Three steps to writing adaptive study protocols in the early phase clinical development of new medicines JO - BMC Med Res Methodol VL - 14 UR - https://doi.org/10.1186/1471-2288-14-84 DO - 10.1186/1471-2288-14-84 ID - Lorch2014 ER - TY - STD TI - Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. von Elm E, editor. PLoS Med. Public Library of Science; 2008;5:e20. ID - ref84 ER - TY - JOUR AU - Hopewell, S. AU - Clarke, M. AU - Moher, D. AU - Wager, E. AU - Middleton, P. AU - Altman, D. G. PY - 2008 DA - 2008// TI - CONSORT for reporting randomised trials in journal and conference abstracts JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(07)61835-2 DO - 10.1016/S0140-6736(07)61835-2 ID - Hopewell2008 ER -